INT118054

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.34
First Reported 2004
Last Reported 2010
Negated 1
Speculated 1
Reported most in Body
Documents 23
Total Number 24
Disease Relevance 11.32
Pain Relevance 1.06

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
arm 22
joint 1
lymph vessels 1
ARMC9 (Homo sapiens)
Pain Link Frequency Relevance Heat
anesthesia 6 94.64 High High
Pain 94 89.44 High High
cva 3 85.12 High High
depression 30 82.48 Quite High
imagery 135 82.16 Quite High
rheumatoid arthritis 4 71.68 Quite High
Angina 2 67.76 Quite High
Inflammation 21 64.08 Quite High
Transcranial magnetic stimulation 3 50.00 Quite Low
backache 2 49.72 Quite Low
Disease Link Frequency Relevance Heat
Lymphedema 197 99.84 Very High Very High Very High
Injury 39 99.84 Very High Very High Very High
Diarrhoea 41 99.48 Very High Very High Very High
Syndrome 228 99.40 Very High Very High Very High
Rectal Cancer 58 98.40 Very High Very High Very High
Dislocations 86 98.36 Very High Very High Very High
Disease 158 96.36 Very High Very High Very High
Metastasis 43 96.20 Very High Very High Very High
Burns 2 95.36 Very High Very High Very High
Non-small-cell Lung Cancer 44 93.44 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A similar survey was sent to control arm surgeons, however, they were not asked to evaluate the individual QIRC strategy interventions.
Regulation (control) of arm in arm associated with rectal cancer
1) Confidence 0.34 Published 2008 Journal BMC Surg Section Body Doc Link PMC2262058 Disease Relevance 0.34 Pain Relevance 0
In the first five patients, surgery was performed under c-arm control.
Regulation (control) of c-arm in arm
2) Confidence 0.23 Published 2004 Journal Knee Surg Sports Traumatol Arthrosc Section Abstract Doc Link 15088083 Disease Relevance 0.38 Pain Relevance 0
For each of the primary and secondary endpoints, three separate t-tests will be used to compare each experimental arm to the control arm in mean change across time of the endpoint.
Regulation (control) of arm in arm
3) Confidence 0.18 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2888787 Disease Relevance 0.16 Pain Relevance 0
The overall survival was significantly better in the erlotinib arm compared with the placebo-controlled arm with a median survival of 6.4 versus 5.9 months [hazard ratio (HR) 0.81; 95% confidence intervals (CI) 0.67, 0.97; P=0.025] and a 1-year survival of 24% versus 17%, respectively.
Regulation (controlled) of arm in arm
4) Confidence 0.15 Published 2007 Journal Core Evidence Section Body Doc Link PMC3012429 Disease Relevance 0.59 Pain Relevance 0
Mean BDI did not change over time for the Sham arm but mean BDI did decline over time in the Fast Left and Slow Right arms.
Neg (not) Regulation (change) of arm in arms
5) Confidence 0.14 Published 2006 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2671728 Disease Relevance 0 Pain Relevance 0
Patients with an additional traumatic injury of the affected arm
Regulation (affected) of arm in arm associated with injury
6) Confidence 0.13 Published 2010 Journal BMC Musculoskelet Disord Section Body Doc Link PMC2887776 Disease Relevance 0.79 Pain Relevance 0.09
In the affected arm of the lymphedema subjects rate of propulsion and velocity analyses were not possible due to the abnormal lymphatic architecture and obscuration of functional lymph vessels by diffuse and dense ICG-laden dermal lymph vessels within the arm.
Regulation (affected) of arm in lymph vessels associated with lymphedema
7) Confidence 0.13 Published 2010 Journal Biomedical Optics Express Section Body Doc Link PMC3005162 Disease Relevance 0.28 Pain Relevance 0
Therapeutic efficacy is typically assessed over several weeks by measuring the change in arm volume as indicated by circumferential arm measurements or water displacement.
Regulation (change) of arm in arm
8) Confidence 0.13 Published 2010 Journal Biomedical Optics Express Section Body Doc Link PMC3005162 Disease Relevance 1.13 Pain Relevance 0.12
Additional traumatic injuries of the affected arm
Regulation (affected) of arm in arm associated with injury
9) Confidence 0.11 Published 2010 Journal BMC Musculoskelet Disord Section Body Doc Link PMC2994812 Disease Relevance 0.75 Pain Relevance 0.12
Following reduction, the affected arm will be put in either a pressure bandage (e.g., Tubigrip®) or a plaster of Paris for three weeks.
Regulation (affected) of arm in arm
10) Confidence 0.11 Published 2010 Journal BMC Musculoskelet Disord Section Body Doc Link PMC2994812 Disease Relevance 0.39 Pain Relevance 0.36
SMRT array CGH, in addition to detecting the ERBB2 locus, revealed several additional discrete changes on the 17q arm in these cell lines.
Regulation (changes) of arm in arm
11) Confidence 0.11 Published 2006 Journal Breast Cancer Res Section Body Doc Link PMC1413994 Disease Relevance 0 Pain Relevance 0
A total of 3,125 children who met the eligibility criteria were enrolled, including 1,017 in the intervention arm and 2,108 in the control arm (Figure 1).
Regulation (enrolled) of arm in arm
12) Confidence 0.09 Published 2010 Journal PLoS Medicine Section Body Doc Link PMC2943441 Disease Relevance 0 Pain Relevance 0
A total of 3,125 children who met the eligibility criteria were enrolled, including 1,017 in the intervention arm and 2,108 in the control arm (Figure 1).
Regulation (enrolled) of arm in arm
13) Confidence 0.09 Published 2010 Journal PLoS Medicine Section Body Doc Link PMC2943441 Disease Relevance 0 Pain Relevance 0
Two patients in the intervention arm and one in the control arm died.
Regulation (control) of arm in arm
14) Confidence 0.09 Published 2010 Journal PLoS Medicine Section Body Doc Link PMC2943441 Disease Relevance 0.58 Pain Relevance 0
The PCD treatment began with• initial truncal decongestion lasting approximately 12 minutes during which a gradient pressure was applied to the trunk and chest areas in a preparative phase that emptied draining basins; and continued with• initial arm preparation, lasting approximately 18 minutes, during which a gradient pressure was applied to the more proximal areas of the arm; and finally culminating with• arm and trunk drainage, lasting approximately 30 minutes during which concerted cycles of mild variable pressure and release were applied sequentially to the limb and trunk in a distal-to-proximal manner.By initially clearing the adjacent quadrant(s), ipsilateral truncal quadrant, and more proximal areas of existing or normal lymph load, the advanced PCD used mimics MLD, and presumably enables receiving lymphatic basins to more effectively receive and process the lymphatic load from the affected arm.
Regulation (affected) of arm in arm
15) Confidence 0.08 Published 2010 Journal Biomedical Optics Express Section Body Doc Link PMC3005162 Disease Relevance 0.06 Pain Relevance 0
Fig. 6Pre- (A) and post- (B and C) PCD treatment images of affected arm of lymphedema subject, BCRL 4.
Regulation (affected) of arm in arm associated with lymphedema
16) Confidence 0.08 Published 2010 Journal Biomedical Optics Express Section Body Doc Link PMC3005162 Disease Relevance 0.66 Pain Relevance 0
Because arm 1 and arm 2 of the B-31 trial are similar to arms A and C of the N9831 trial, the studies were amended to include a joint statistical analysis combining arm 1 and arm A for comparison with arm 2 and arm C.
Regulation (combining) of arm in joint
17) Confidence 0.07 Published 2007 Journal BMC Cancer Section Body Doc Link PMC1959236 Disease Relevance 0.66 Pain Relevance 0.07
Tapping on the foreign arm and on the box continued for another 2 minutes and 30 seconds.
Regulation (continued) of arm in arm
18) Confidence 0.06 Published 2010 Journal PLoS ONE Section Body Doc Link PMC2827559 Disease Relevance 0 Pain Relevance 0.14
These treatments are based on the ability of the patients to perform actions with the affected hand or arm and therefore, require residual motor ability.
Regulation (affected) of arm in arm
19) Confidence 0.05 Published 2010 Journal Frontiers in Neuroscience Section Body Doc Link PMC2944670 Disease Relevance 0.23 Pain Relevance 0.07
Median PFS was 6 months in the THAL arm compared to 4 months in the control arm [107].
Regulation (control) of arm in arm
20) Confidence 0.03 Published 2010 Journal Journal of Oncology Section Body Doc Link PMC2804796 Disease Relevance 1.22 Pain Relevance 0.04

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox